The long-awaited trial comes after much preclinical cell work on more than 350 rats, 50 immunodeficient mice and 32 non-human primates. "After 20 years in the stem cell area and a daily practice of cardiac surgery, I am very cautiously optimistic," Principle Investigator Philippe Menasche told Bioscience Technology .
http://ift.tt/1rWVtKc
http://ift.tt/1rWVtKc
No comments:
Post a Comment